ASHLEY MURPHY: Open Payments
NPI 1356015051 · WATERBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$511 in 21 payments from 13 companies in 2025. Trend: 2023 $146 · 2024 $691 · 2025 $511
Food & beverage: $491Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $135 |
| Amgen Inc. | 3 | $83 |
| Novo Nordisk Inc | 2 | $55 |
| Cycle Pharmaceuticals Inc | 1 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $31 |
| Baxter Healthcare | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Calliditas Therapeutics US Inc. | 1 | $21 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
Products named: Vanrafia, UPLIZNA, Venxxiva, Wegovy, Kerendia, TAVNEOS, Renal - PD, ULTOMIRIS.
Industry payments across CT — which companies pay providers there.
